Tetsuro Yoshimaru

1 Patent

• US125952892026

  Therapeutic Agent for Breast Cancer Comprising BIG3-PHB2 Interaction-inhibiting Peptide Derived from PHB2

  ONCOTHERAPY SCIENCE, Inc.

  0 cites